Cargando…
Metformin in heart failure patients
The use of metformin was considered a contraindication in heart failure patients because of the potential risk of lactic acidosis; however, more recent evidence has shown that this should no longer be the case. We reviewed the current literature and the recent guideline to correct the misconception.
Autores principales: | Kinsara, Abdulhalim Jamal, Ismail, Yasser Mansour |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902828/ https://www.ncbi.nlm.nih.gov/pubmed/29455774 http://dx.doi.org/10.1016/j.ihj.2017.05.009 |
Ejemplares similares
-
Gender differences in patients presenting with non-ST segment elevation myocardial infarction in the STAR registry
por: Kinsara, Abdulhalim Jamal, et al.
Publicado: (2021) -
Ambulatory blood pressure monitoring in daily practice
por: Kinsara, Abdulhalim Jamal
Publicado: (2017) -
The Echocardiography Society of Saudi Heart Association Recommendation on Quality and Laboratory Accreditation Guideline and Standards
por: Kinsara, Abdulhalim Jamal, et al.
Publicado: (2020) -
Flash’O real-world evidence programme – Attitude and practices toward the use of omega-3 FA by physicians from Middle East Countries
por: Kinsara, Abdulhalim Jamal, et al.
Publicado: (2023) -
STEMI vs NSTEACS management trends in non-invasive hospital
por: Kinsara, Abdulhalim Jamal, et al.
Publicado: (2016)